Evidence map›Paper›PMID 41058235›Full record

ArticleThe American journal of psychiatry2026

Reduced Threat-Related Neural Efficiency: A Possible Biomarker for Pediatric Anxiety Disorders.

Julia O Linke, Reut Naim, Simona P Haller, Parmis Khosravi, Beck Scheinberg, Meghan E Byrne, Anita Harrewijn, Ellen Leibenluft, Melissa A Brotman, Anderson M Winkler and 1 more

Abstract read
In one paragraph

Article in The American journal of psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Julia O LinkeDepartment of Psychology, Freiburg University, Freiburg im Breisgau, Germany.
Reut NaimSchool of Psychological Sciences, Tel Aviv University, Tel Aviv, Israel.
Simona P HallerEmotion and Development Branch, NIMH, Bethesda, MD.
Parmis KhosraviEmotion and Development Branch, NIMH, Bethesda, MD.
Beck ScheinbergEmotion and Development Branch, NIMH, Bethesda, MD.
Meghan E ByrneEmotion and Development Branch, NIMH, Bethesda, MD.
Anita HarrewijnSchool of Social and Behavioral Sciences, Erasmus University Rotterdam, Rotterdam, Netherlands.
Ellen LeibenluftEmotion and Development Branch, NIMH, Bethesda, MD.
Melissa A BrotmanEmotion and Development Branch, NIMH, Bethesda, MD.
Anderson M WinklerDivision of Human Genetics, School of Medicine, University of Texas Rio Grande Valley, Brownsville.
Daniel S PineEmotion and Development Branch, NIMH, Bethesda, MD.

Funding

fMRI Studies Of Pediatric Mood And Anxiety DisordersZIAMH002781 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI PINE, DANIEL · 2009 to 2025
$41.5M
Intramural NIH HHS ZIA MH002781
6 · The paper itself

Abstract

objectivePediatric anxiety disorders are common and predict adult psychopathology, yet current treatments, such as cognitive-behavioral therapy (CBT), produce lasting remission in less than 50% of affected youths. To support the search for improved, mechanistically grounded interventions, this study evaluated neural efficiency, defined as similarity in functional connectivity between a threat task and rest, as a potential biomarker. The study evaluated neural efficiency in relation to anxiety diagnosis and treatment response.

methodsThe authors compared 103 youths with an anxiety disorder diagnosis (mean age, 12.5 years [SD=2.91], 62% female) to 103 youths with no psychiatric diagnosis (mean age, 13.4 years [SD=2.58], 53% female). Participants completed functional MRI while resting and during a dot-probe task with threatening faces. Neural efficiency was calculated as partial correlations between intrinsic and task-related functional connectivity patterns across the whole brain. Four-month test-retest reliability as well as relationships with anxiety and response to exposure-based CBT were examined.

resultsNeural efficiency demonstrated satisfactory test-retest reliability (intraclass correlation coefficient=0.65) in healthy youths over a period of 11 to 18 weeks. Neural efficiency was significantly negatively related to anxiety as both a diagnostic category (t=2.62, d=0.29) and a symptom dimension (r=-0.18). Although it did not change after CBT, lower neural efficiency at baseline was significantly associated with poorer treatment response in a subset of 80 anxious youths who underwent CBT (β=-11.88, χ

conclusionsNeural efficiency, measured as network reconfiguration between rest and task, holds promise as a biomarker in pediatric anxiety. Its association with CBT response suggests that it might aid in patient stratification and offer a target for interventions aimed at enhancing CBT efficacy.

Indexed as

Anxiety DisordersBrainFearAdolescentBiomarkersChildCognitive Behavioral TherapyFemaleHumansMagnetic Resonance ImagingMaleReproducibility of ResultsBiomarkersAnxiety DisordersBiological MarkersNeuroimagingPsychotherapy

Identifiers

PMID41058235
PMCPMC12614269

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.